113 related articles for article (PubMed ID: 1462293)
21. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
[TBL] [Abstract][Full Text] [Related]
22. [The effect of "triple therapy" on the eradicating of H. pylori and the healing of a duodenal ulcer. The initial study and 6 months later].
Gisbert JP; Boixeda D; de Rafael L; Martín de Argila C; Bermejo F; García Plaza A
Rev Esp Enferm Dig; 1995 Mar; 87(3):193-8. PubMed ID: 7742047
[TBL] [Abstract][Full Text] [Related]
23. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
24. [Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Labenz J; Gyenes E; Rühl GH; Börsch G
Med Klin (Munich); 1993 May; 88(5):297-9. PubMed ID: 8326916
[TBL] [Abstract][Full Text] [Related]
25. Treatment strategies for symptom resolution, healing, and Helicobacter pylori eradication in duodenal ulcer patients.
Rune SJ
Scand J Gastroenterol Suppl; 1994; 205():45-7. PubMed ID: 7863241
[TBL] [Abstract][Full Text] [Related]
26. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Buzás György M; Székely E; Illyés G; Széles I
Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
[TBL] [Abstract][Full Text] [Related]
27. Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study.
Forné M; Viver JM; Espinós JC; Coll I; Tresserra F; Garau J
Am J Gastroenterol; 1995 May; 90(5):718-21. PubMed ID: 7733075
[TBL] [Abstract][Full Text] [Related]
28. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori and peptic ulcer disease.
Ateshkadi A; Lam NP; Johnson CA
Clin Pharm; 1993 Jan; 12(1):34-48. PubMed ID: 8428432
[TBL] [Abstract][Full Text] [Related]
30. Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate.
Karita M; Morshed MG; Ouchi K; Okita K
Am J Gastroenterol; 1994 Jul; 89(7):1032-5. PubMed ID: 8017361
[TBL] [Abstract][Full Text] [Related]
31. Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients.
Vetvik K; Schrumpf E; Mowinckel P; Aase S; Andersen KJ
Scand J Gastroenterol; 1994 Nov; 29(11):995-1000. PubMed ID: 7871380
[TBL] [Abstract][Full Text] [Related]
32. [Helicobacter pylori and gastroduodenal ulcers].
Nishio A; Yamamoto T; Hajiro K
Nihon Rinsho; 1993 Dec; 51(12):3210-4. PubMed ID: 8283635
[TBL] [Abstract][Full Text] [Related]
33. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori.
Wilhelmsen I; Berstad A
Scand J Gastroenterol; 1994 Oct; 29(10):874-9. PubMed ID: 7839092
[TBL] [Abstract][Full Text] [Related]
34. Spiramycin in triple therapy of Helicobacter pylori-associated peptic ulcer disease. An open pilot study with 12-month follow-up.
Berstad A; Berstad K; Wilhelmsen I; Hatlebakk JG; Nesje LB; Hausken T
Aliment Pharmacol Ther; 1995 Apr; 9(2):197-200. PubMed ID: 7605862
[TBL] [Abstract][Full Text] [Related]
35. Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates.
Louw JA; Zak J; Lucke W; Le Roux E; Jaskiewicz K; Winter T; Lastovica A; Marks IN
Scand J Gastroenterol Suppl; 1992; 191():28-31. PubMed ID: 1411294
[TBL] [Abstract][Full Text] [Related]
36. Spiramycin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazole.
Olafsson S; Berstad A; Bang CJ; Nysaeter G; Coll P; Tefera S; Hatlebakk JG; Hausken T; Olafsson T
Aliment Pharmacol Ther; 1999 May; 13(5):651-9. PubMed ID: 10233189
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori infection.
Axon AT
J Antimicrob Chemother; 1993 Jul; 32 Suppl A():61-8. PubMed ID: 8407699
[TBL] [Abstract][Full Text] [Related]
38. Is there a place for antacids in the treatment of Helicobacter pylori infection?
Berstad K; Weberg R; Berstad A
Scand J Gastroenterol; 1992 Dec; 27(12):1006-10. PubMed ID: 1475615
[TBL] [Abstract][Full Text] [Related]
39. Phospholipase A2 activity in gastric juice from patients with active and H. pylori-eradicated healed duodenal ulcer.
Berstad K; Sjödahl R; Berstad A
Aliment Pharmacol Ther; 1994 Apr; 8(2):175-80. PubMed ID: 8038348
[TBL] [Abstract][Full Text] [Related]
40. Increased healing of gastric and duodenal ulcers in a controlled trial using tripotassium dicitrato-bismuthate.
Lee SP; Nicholson GI
Med J Aust; 1977 May; 1(22):808-12. PubMed ID: 329077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]